Theriva Biologics, Inc. (TOVX)
0.2466
+0.04
(+17.21%)
USD |
NYAM |
Jan 02, 12:45
Theriva Biologics Research and Development Expense (Annual): 12.03M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |
| Oragenics, Inc. | 4.114M |
| NanoViricides, Inc. | 5.549M |
| Actinium Pharmaceuticals, Inc. | 29.88M |